The Miranza group is going to broaden horizons, with plans to open the first eye clinics in Portugal by March of next year, as part of an international expansion plan created by the Cinco Días newspaper.
“The presence of Miranza in Portugal will be a reality in the first quarter of 2022”, confirms the general director of the group, Ramón Berra, in a statement to the Spanish newspaper.
Although still unconfirmed, it is foreseeable that at least the first Miranza clinics will open their doors in Lisbon and Porto, said the economic publication.
Miranza, owned by Magnum Capital, a venture capital company founded by Ángel Corcóstegui, former managing director of Santander, was founded in 2019 with the purchase of the Catalan group Instituto de Microcirurgia Ocular (IMO) and four other clinics.
According to the daily newspaper Cinco Días, Magnum Capital’s strategy is to create a leading group in ocular medicine in Spain, with Ramón Berra pointing out that specialization in complex pathologies is a mark that distinguishes Miranza from other companies in the field.
The group is chaired by Borja Corcóstegui, co-founder of the IMO and brother of the president of Magnum Capital, as the former banker comes from a family with a tradition in ophthalmology. The venture capital firm controls 90% of the Miranza group, taking advantage of the remainder in the hands of professionals from whom clinics were acquired that revert to the group.
In the last two weeks alone, it acquired two clinics (one in Andalusia and the other in Andorra), absorbing the volume of units in its portfolio.
The group, which has approximately 30 centers and employs 850 employees, including 275 ophthalmologists, expects to close the year with a turnover of around 78.5 million euros.